PROVIDER PROFILE · NPI 1578726428

Robert DebadtsRPAC

PRESCRIBING · PART D · 2024
Total Rx claims
1,385
Beneficiaries
Total drug cost
$204K
Distinct drugs
32
Brand share
15.6%
Top prescribed drugs
Hydralazine Hcl137 claims
Torsemide110 claims
Carvedilol79 claims
QUALITY · MIPS · 2024
Final MIPS score
96.6
Quality
74.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.91%
APM Entity